<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05047744</url>
  </required_header>
  <id_info>
    <org_study_id>KUK-UNF-21-001</org_study_id>
    <nct_id>NCT05047744</nct_id>
  </id_info>
  <brief_title>Dual Mobility Total Joint Prosthesis (Touch) for Thumb Carpometacarpal Joint Osteoarthritis</brief_title>
  <official_title>Dual Mobility Total Joint Prosthesis (Touch) for Thumb Carpometacarpal Joint Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kepler University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kepler University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The dual mobility concept currently represents the newest generation of thumb carpometacarpal&#xD;
      prostheses. The aim of this study was to evaluate the outcomes of TOUCH® prosthesis. From&#xD;
      September 2019 to December 2023,a minimum of 100 prosthesis shall be implanted in patients&#xD;
      suffering from symptomatic stage III osteoarthritis. All included patients will follow a&#xD;
      systematic follow-up regimen (4, 8, 16 weeks, 6, and 12 months as well as 24 months&#xD;
      postoperatively).&#xD;
&#xD;
      Radiographics, ROM, VAS, DASH and Pinch grip are measured. Aim of the study is to compare&#xD;
      clinical outcome of dual mobility prosthesis with common results of CMC I Prosthesis in&#xD;
      literature.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The dual mobility concept currently represents the newest generation of thumb carpometacarpal&#xD;
      prostheses. The aim of this study was to evaluate the outcomes of TOUCH® prosthesis. From&#xD;
      September 2019 to December 2023,a minimum of 100 prosthesis shall be implanted in patients&#xD;
      suffering from symptomatic stage III osteoarthritis. All included patients will follow a&#xD;
      systematic follow-up regimen (4, 8, 16 weeks, 6, and 12 months as well as 24 months&#xD;
      postoperatively).&#xD;
&#xD;
      Radiographics, ROM, VAS, DASH and Pinch grip are measured. Aim of the study is to compare&#xD;
      clinical outcome of dual mobility prosthesis with common results of CMC I Prosthesis in&#xD;
      literature.&#xD;
&#xD;
      The Study is designed to give clinical results after one year, 2 years and also long time&#xD;
      results in the future.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Prospective non randomized Clinical Trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>DASH Score</measure>
    <time_frame>24 months</time_frame>
    <description>DASH Score is taken before Surgery and after 6, 12 and 24 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective Pain</measure>
    <time_frame>24 months</time_frame>
    <description>patients report about subjective Pain level in average at 6, 12 and 24 months in a VAS scale (0-10)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Validation of CMC I Prosthesis in CMC I Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Prosthesis Cohort</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Surgery dual mobility Prosthesis</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Touch Dual Mobility CMC I Prosthesis</intervention_name>
    <description>Surgery</description>
    <arm_group_label>Prosthesis Cohort</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  CMC I Osteoarthritis /Stage III)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  CMC I (osteoarthritis / Other Stage than III)&#xD;
&#xD;
          -  Anticoagulation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stefan M Froschauer, MD</last_name>
    <phone>004373278061020</phone>
    <email>stefan.froschauer@kepleruniklinikum.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Oskar Kwasny, Prof</last_name>
    <phone>004373278061010</phone>
    <email>oskar.kwasny@kepleruniklinikum.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kepler Universitaetsklinikum GmbH</name>
      <address>
        <city>Linz</city>
        <zip>4020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan M Froschauer, MD</last_name>
      <phone>+4373278061020</phone>
      <email>stefan.froschauer@kepleruniklinikum.at</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 8, 2021</study_first_submitted>
  <study_first_submitted_qc>September 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2021</study_first_posted>
  <last_update_submitted>September 8, 2021</last_update_submitted>
  <last_update_submitted_qc>September 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CMC I Osteoarthritis, Total Joint Replacement, Hand Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

